This guidance replaces sections 1.2–1.4 of 'Guidance on the use of coronary artery stents' (NICE technology appraisal guidance 71).
Sections 1.1 and 1.5 of technology appraisal guidance 71 recommend when to use a stent. This part review recommends under what circumstances a drug-eluting stent should be used.
1.1 Drug-eluting stents are recommended for use in percutaneous coronary intervention for the treatment of coronary artery disease, within their instructions for use, only if:
the target artery to be treated has less than a 3-mm calibre or the lesion is longer than 15 mm, and
the price difference between drug-eluting stents and bare-metal stents is no more than £300.